Home
>
National Drug Code (NDC)
>
RISPERIDONE
RISPERIDONE - 51991-317-01 - (RISPERIDONE)
Drug Information of RISPERIDONE
| Product NDC: | 51991-317 |
| Proprietary Name: | RISPERIDONE |
| Non Proprietary Name: | RISPERIDONE |
| Active Ingredient(s): | .5 mg/1 & nbsp; RISPERIDONE |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of RISPERIDONE
| Product NDC: | 51991-317 |
| Labeler Name: | Breckenridge Pharmaceutical, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA201003 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20120425 |
Package Information of RISPERIDONE
| Package NDC: | 51991-317-01 |
| Package Description: | 100 TABLET in 1 BOTTLE (51991-317-01) |
NDC Information of RISPERIDONE
| NDC Code | 51991-317-01 |
| Proprietary Name | RISPERIDONE |
| Package Description | 100 TABLET in 1 BOTTLE (51991-317-01) |
| Product NDC | 51991-317 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | RISPERIDONE |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20120425 |
| Marketing Category Name | ANDA |
| Labeler Name | Breckenridge Pharmaceutical, Inc. |
| Substance Name | RISPERIDONE |
| Strength Number | .5 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Atypical Antipsychotic [EPC] |
